China · Delayed Price · Currency is CNY Jinyu Bio-technology Statistics
Total Valuation
SHA:600201 has a market cap or net worth of CNY 16.49 billion. The enterprise value is 15.29 billion.
| Market Cap | 16.49B |
| Enterprise Value | 15.29B |
Important Dates
The last earnings date was Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Jun 26, 2025 |
Share Statistics
SHA:600201 has 1.09 billion shares outstanding. The number of shares has increased by 2.56% in one year.
| Current Share Class | 1.09B |
| Shares Outstanding | 1.09B |
| Shares Change (YoY) | +2.56% |
| Shares Change (QoQ) | -5.81% |
| Owned by Insiders (%) | 3.43% |
| Owned by Institutions (%) | 15.68% |
| Float | 923.99M |
Valuation Ratios
The trailing PE ratio is 167.67 and the forward PE ratio is 62.88.
| PE Ratio | 167.67 |
| Forward PE | 62.88 |
| PS Ratio | 11.85 |
| PB Ratio | 2.96 |
| P/TBV Ratio | 3.36 |
| P/FCF Ratio | 106.09 |
| P/OCF Ratio | 54.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 59.47, with an EV/FCF ratio of 98.37.
| EV / Earnings | 146.62 |
| EV / Sales | 10.95 |
| EV / EBITDA | 59.47 |
| EV / EBIT | n/a |
| EV / FCF | 98.37 |
Financial Position
The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.66 |
| Quick Ratio | 3.19 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.01 |
| Interest Coverage | 54.72 |
Financial Efficiency
Return on equity (ROE) is 1.82% and return on invested capital (ROIC) is 0.58%.
| Return on Equity (ROE) | 1.82% |
| Return on Assets (ROA) | 0.24% |
| Return on Invested Capital (ROIC) | 0.58% |
| Return on Capital Employed (ROCE) | 0.44% |
| Weighted Average Cost of Capital (WACC) | 8.59% |
| Revenue Per Employee | 799,600 |
| Profits Per Employee | 59,927 |
| Employee Count | 1,740 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, SHA:600201 has paid 5.34 million in taxes.
| Income Tax | 5.34M |
| Effective Tax Rate | 5.07% |
Stock Price Statistics
The stock price has increased by +117.12% in the last 52 weeks. The beta is 0.79, so SHA:600201's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +117.12% |
| 50-Day Moving Average | 14.73 |
| 200-Day Moving Average | 12.58 |
| Relative Strength Index (RSI) | 57.99 |
| Average Volume (20 Days) | 23,765,691 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600201 had revenue of CNY 1.39 billion and earned 104.27 million in profits. Earnings per share was 0.09.
| Revenue | 1.39B |
| Gross Profit | 724.94M |
| Operating Income | 25.73M |
| Pretax Income | 105.34M |
| Net Income | 104.27M |
| EBITDA | 286.56M |
| EBIT | 25.73M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 1.32 billion in cash and 1.20 million in debt, with a net cash position of 1.32 billion or 1.21 per share.
| Cash & Cash Equivalents | 1.32B |
| Total Debt | 1.20M |
| Net Cash | 1.32B |
| Net Cash Per Share | 1.21 |
| Equity (Book Value) | 5.56B |
| Book Value Per Share | 4.74 |
| Working Capital | 1.73B |
Cash Flow
In the last 12 months, operating cash flow was 301.31 million and capital expenditures -145.88 million, giving a free cash flow of 155.42 million.
| Operating Cash Flow | 301.31M |
| Capital Expenditures | -145.88M |
| Depreciation & Amortization | 260.83M |
| Net Borrowing | -16.74M |
| Free Cash Flow | 155.42M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 52.11%, with operating and profit margins of 1.85% and 7.49%.
| Gross Margin | 52.11% |
| Operating Margin | 1.85% |
| Pretax Margin | 7.57% |
| Profit Margin | 7.49% |
| EBITDA Margin | 20.60% |
| EBIT Margin | 1.85% |
| FCF Margin | 11.17% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.25%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | -62.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.87% |
| Buyback Yield | -2.56% |
| Shareholder Yield | -2.32% |
| Earnings Yield | 0.63% |
| FCF Yield | 0.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 25, 2018. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 25, 2018 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |